Paediatric Use The safety of voriconazole was investigated in 245 paediatric patients aged 2 to < 12 years who were treated with voriconazole in pharmacokinetic studies (87 paediatric patients) and in compassionate use programs (158 paediatric patients).
Vorikonasooli ohutust uuriti 245 lapsel vanuses 2... < 12 aastat, keda raviti farmakokineetilistes uuringutes (87 last) ja ravimi tasuta kasutamise programmi raames (158 last) vorikonasooliga.